Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x100px

Organisation › Details

Merck (US) (MSD) (Group)

https://www.merck.com

	Start	1990-01-01 existent
	Industry	pharmaceutical
	Person	Davis, Robert M. (Rob) (Merck (US) 202107– CEO before CFO formerly Baxter 200703 CFO)

	Street	One Merck Drive P.O. Box 100
	City	08889-0100 Whitehouse Station, NJ
		Address record changed: 2020-12-02

Basic data	Employees	I: 50,001 to 100,0 (2007-11-13)
	Currency	USD
	Annual sales	22,636,000,000 (sales, worldwide 2006-12-31)
	Profit	4,433,800,000 (2006-12-31)


		Record changed: 2023-07-10

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for Merck (US) (MSD) (Group)

[1] N-Power Medicine, Inc.. (7/1/24). "Press Release: N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials". Redwood City, CA....
[2] N-Power Medicine, Inc.. (7/1/24). "Press Release: N-Power Medicine Emerges with Series B Funding to Bolster Access to Innovative Oncology Clinical Trials". Redwood City, CA....
[3] Merck & Co., Inc.. (5/29/24). "Press Release: Merck to Acquire EyeBio". Rahway, NJ & New York, NY....
[4] Owkin. (12/19/23). "Press Release: Owkin Enters Collaboration Agreement with MSD to Develop AI-powered Diagnostics for Cancer"....
[5] Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA....
[6] Merck & Co., Inc.. (10/19/23). "Press Release: Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs". Basking Ridge, NJ & Rahway, NJ....
[7] AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal....
[8] Anavo Therapeutics B.V.. (5/2/23). "Press Release: Anavo Therapeutics Extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic". Leiden & Heidelberg....
[9] Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna....
[10] Merck & Co., Inc.. (12/21/22). "Press Release: Lynparza (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone Approved in the EU as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer". Rahway, NJ....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]